A case of Hand-Foot Syndrome Due to Chemotherapy

Liposomal doxorubicin (LD)that is an anthracycline group antineoplastic drug, is used in the treatment of aggressive non-Hodgkin's lymphoma, resistant ovarian and breast cancers and AIDS-related Kaposi's sarcoma. A rare and dose-dependent side effect of such chemotherapeutics, is Hand-foot syndrome and it should be known by emergency physicians because of the patients' first contact with the hospital is in emergency department. In this article, we present a case who was admitted to the emergency department with complaints of redness, swelling and pain in the hands and feet after the liposomal doxorubicin treatment for metastatic ovarian carcinoma